Literature DB >> 17075251

Cough sensitivity in pure cough variant asthma elicited using continuous capsaicin inhalation.

Takeo Nakajima1, Yoshihiro Nishimura, Teruaki Nishiuma, Yoshikazu Kotani, Hiroyuki Nakata, Mitsuhiro Yokoyama.   

Abstract

BACKGROUND: Cough variant asthma has recently been described, mainly as airway inflammation in relation to bronchial asthma, but the relationship between the two types of asthma remains unclear. Further studies of cough receptor sensitivity are necessary to fully characterize cough variant asthma.
METHODS: We assessed the relevance of testing cough sensitivity using an Astograph with continuous capsaicin inhalation, and compared the results with those obtained using intermittent inhalation. We showed the clinical applicability of testing cough sensitivity (0.156-80 microM capsaicin; five or more coughs, 1 minute of continuous inhalation at each concentration) using this method. We compared cough sensitivity among patients with pure cough variant asthma who did not develop bronchial asthma after an observation period of at least 1 year, patients with bronchial asthma and healthy individuals.
RESULTS: The continuous cough sensitivity test using the Astograph was reproducible and reliable. Cough sensitivity in patients with pure cough variant asthma was significantly higher than that in healthy individuals.
CONCLUSIONS: The cough sensitivity of patients with cough variant asthma is not necessarily identical to that of healthy individuals.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17075251     DOI: 10.2332/allergolint.55.149

Source DB:  PubMed          Journal:  Allergol Int        ISSN: 1323-8930            Impact factor:   5.836


  11 in total

Review 1.  Transient Receptor Potential Channels and Chronic Airway Inflammatory Diseases: A Comprehensive Review.

Authors:  Yang Xia; Lexin Xia; Lingyun Lou; Rui Jin; Huahao Shen; Wen Li
Journal:  Lung       Date:  2018-08-09       Impact factor: 2.584

Review 2.  Breathtaking TRP channels: TRPA1 and TRPV1 in airway chemosensation and reflex control.

Authors:  Bret F Bessac; Sven-Eric Jordt
Journal:  Physiology (Bethesda)       Date:  2008-12

Review 3.  TRPV1 antagonists as potential antitussive agents.

Authors:  Robbie L McLeod; Craig C Correll; Yanlin Jia; John C Anthes
Journal:  Lung       Date:  2007-10-10       Impact factor: 2.584

4.  Objective and Subjective Measurement of Cough in Asthma: A Systematic Review of the Literature.

Authors:  Joshua Holmes; Liam G Heaney; Lorcan P A McGarvey
Journal:  Lung       Date:  2022-04-13       Impact factor: 3.777

5.  TRPV1: A Potential Drug Target for Treating Various Diseases.

Authors:  Rafael Brito; Sandeep Sheth; Debashree Mukherjea; Leonard P Rybak; Vickram Ramkumar
Journal:  Cells       Date:  2014-05-23       Impact factor: 6.600

Review 6.  Transient receptor potential (TRP) channels in the airway: role in airway disease.

Authors:  M S Grace; M Baxter; E Dubuis; M A Birrell; M G Belvisi
Journal:  Br J Pharmacol       Date:  2014-05       Impact factor: 8.739

Review 7.  Comparative effects of capsaicin in chronic obstructive pulmonary disease and asthma (Review).

Authors:  Mihai-Daniel Dumitrache; Ana Stefania Jieanu; Cristian Scheau; Ioana Anca Badarau; George Denis Alexandru Popescu; Ana Caruntu; Daniel Octavian Costache; Raluca Simona Costache; Carolina Constantin; Monica Neagu; Constantin Caruntu
Journal:  Exp Ther Med       Date:  2021-06-29       Impact factor: 2.447

Review 8.  Pre-clinical studies in cough research: role of Transient Receptor Potential (TRP) channels.

Authors:  Megan S Grace; Eric Dubuis; Mark A Birrell; Maria G Belvisi
Journal:  Pulm Pharmacol Ther       Date:  2013-03-06       Impact factor: 3.410

Review 9.  Peripheral mechanisms II: the pharmacology of peripherally active antitussive drugs.

Authors:  D Spina; I McFadzean; F K R Bertram; C P Page
Journal:  Handb Exp Pharmacol       Date:  2009

Review 10.  Involvement of Neural Transient Receptor Potential Channels in Peripheral Inflammation.

Authors:  Harold A Silverman; Adrian Chen; Nigel L Kravatz; Sangeeta S Chavan; Eric H Chang
Journal:  Front Immunol       Date:  2020-10-23       Impact factor: 7.561

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.